Pregestational Diabetes Mellitus Impaired Fasting Glucose ,Gestational Diabetes Mellitus
Conditions
Interventions
Experimental Group:Wear Continuous Glucose Monitors and receive online guidance on diet and exercise.
Sponsors
Tongzhou Maternal and Child Health Care Hospital of Beijing
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Pregnant women who were first diagnosed with gestational hyperglycemia during early to mid-pregnancy and voluntarily participated in the study.According to the "Guidelines for the Diagnosis and Treatment of Hyperglycemia in Pregnancy (2022)," hyperglycemia in pregnancy includes pregestational diabetes mellitus (PGDM), impaired fasting glucose (IFG), and gestational diabetes mellitus (GDM). (1) IFG was diagnosed by fasting blood glucose (FPG) >=5.6mmol/l at the first pregnancy examination. (2) In the first trimester, FPG was in the range of 5.1mmol/1-5.6mmol/1, and fpg>=5.1mmol/l was reexamined at 24-28 weeks to diagnose GDM. OGTT was performed for fpg=5.1mmol/1 or 1h>=10.0mmol/l or 2h>=8.5mmol/l to diagnose GDM. (3) PGDM was diagnosed if the diagnosis was not confirmed before pregnancy and the blood glucose increased during pregnancy reached any of the following criteria: fpg>=7.0mmol/1; Accompanied by typical symptoms of hyperglycemia or hyperglycemic crisis, and any blood glucose >= 11.1mmol/l (except OGTT); Hba1c>=6.5.
Exclusion criteria
Exclusion criteria: 1. Pregnant women with a pre-pregnancy diagnosis of type 1 or type 2 diabetes; 2. Pregnant women with pre-existing underlying conditions, including hypertension, kidney disease, immune system disorders, tumors, impaired glucose tolerance, insulin resistance, coagulation abnormalities, etc; 3. Pregnant women diagnosed during pregnancy with underlying conditions such as kidney disease, immune system disorders, tumors, coagulation abnormalities, etc.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pregnancy Complications;Adverse Pregnancy Outcomes;Adverse Neonatal Outcomes; | — |
Secondary
| Measure | Time frame |
|---|---|
| Acceptability;Blood glucose related indicators;Types and Dosages of Insulin;Medical costs, social costs; | — |
Countries
China
Contacts
Public ContactJiao Yujie
Tongzhou Maternal and Child Health Care Hospital of Beijing
Outcome results
None listed